Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
INCLUSION COMPLEX, ITS PRODUCTION, PRODUCTION OF ALKALI CLAVULANATE AND STABLE GALENICAL PREPARATION CONTAINING INCLUSION COMPLEX
Document Type and Number:
Japanese Patent JPH072905
Kind Code:
A
Abstract:

PURPOSE: To obtain a novel inclusion complex of clavulanic acid and hydrophilic or hydrophobic β-cyclodextrin.

CONSTITUTION: An inclusion complex is characterised by that a molar ratio of clavulanic acid represented by the formula or its pharmacologically acceptable alkali salt to a hydrophilic or hydrophobic β-cyclodextrin deriv. is about 1:1. The inclusion complex is used as an intermediate compd. when pure clavulanic acid or its alkali salt is isolated and a stable sustained release preparation contains the inclusion complex. Further, the inclusion complex consists of clavulanic acid and its pharmacologically acceptable alkali salt and a hydrophilic β-CD deriv. or a hydrophobic β-CD' deriv. A galenical reparation being a medicine useful for treatment of infectious diseases is composed of a combination of the inclusion complex and amoxicillin trihydrate and has immediate action and sustained action. In the formula, R is hydrogen or an alkali metal.


Inventors:
ZMITEK JANKO (SI)
FERCEJ-TEMERJOTOV DARJA (SI)
VERHNJAK KATARINA (SI)
KOTNIK SONJA (SI)
KOVACIC MATEJA (SI)
Application Number:
JP16936193A
Publication Date:
January 06, 1995
Filing Date:
July 08, 1993
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
LEK TOVARNA FARMACEVTSKIH (SI)
International Classes:
A61K9/08; A61K9/107; A61K9/16; A61K9/20; A61K9/22; A61K9/48; A61K31/42; A61K31/424; A61K47/40; A61K47/48; A61P31/04; A61P43/00; C07D503/00; C07D503/18; C08B37/16; C07D498/00; (IPC1-7): C08B37/16; A61K9/08; A61K9/107; A61K9/16; A61K9/20; A61K9/48; A61K31/42; A61K47/40; C07D503/00
Attorney, Agent or Firm:
Shigeru Yagita (2 outside)



 
Next Patent: 表面形状測定機